nad+ glp-1 Sleep Support+ | with & L-Theanine NAD+ — Compounded Injection (Olympia)

Chen J, Jiao XF, Zhang L, Zhang M, Zeng L, Liu D et al (2023) The impact of levothyroxine therapy on pregnancy and neonatal outcomes in euthyroid pregnant women with thyroid autoimmunity: a systematic review, meta-analysis and trial sequential analysis

You cant do a [randomized clinical trial] on all cancer types, following patients for 20 years

Why Employers Are Zeroing In On GLP-1s The numbers tell the story: 40% of US adults are living with obesity, with projections closer to 50% by 2030 Employers spend $6,472 more per year on employees with obesity than on healthy-weight employees across medical, productivity, disability, and workers comp Individuals who use GLP-1s can lose between 2.5% and 20% of their initial body weight when taking the medication as instructed Employers want to support prevention, not wait until employees are sicker to qualify for care

Existing educational materials are often inadequate, but they found that visual aids can improve awareness